دورية أكاديمية
Modeling the burden of cardiovascular disease in Turkey.
| العنوان: | Modeling the burden of cardiovascular disease in Turkey. |
|---|---|
| المؤلفون: | Balbay Y, Gagnon-Arpin I; The Conference Board of Canada; Ottawa, Ontario-Canada. gagnonarpin@conferenceboard.ca., Malhan S, Öksüz ME, Sutherland G, Dobrescu A, Villa G, Ertuğrul G, Habib M |
| المصدر: | Anatolian journal of cardiology [Anatol J Cardiol] 2018 Oct; Vol. 20 (4), pp. 235-240. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: KARE publishing Country of Publication: Turkey NLM ID: 101652981 Publication Model: Print Cited Medium: Internet ISSN: 2149-2271 (Electronic) Linking ISSN: 21492263 NLM ISO Abbreviation: Anatol J Cardiol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2023- : İstanbul, Turkey : KARE publishing Original Publication: İstanbul, Turkey : Aves, [2015]- |
| مواضيع طبية MeSH: | Cardiovascular Diseases/*epidemiology, Absenteeism ; Adult ; Aged ; Aged, 80 and over ; Cardiovascular Diseases/economics ; Cardiovascular Diseases/etiology ; Female ; Health Care Costs ; Hospitalization ; Humans ; Male ; Middle Aged ; Prevalence ; Risk Factors ; Turkey/epidemiology ; Young Adult |
| مستخلص: | Objective: This study aims to estimate the current and future burden of cardiovascular diseases (CVD) in Turkey. Methods: A burden-of-disease model was developed that included inputs on population growth, prevalence, and incidence of ischemic disease (IHD) and cerebrovascular disease (CeVD), prevalence of modifiable risk factors, mortality rates, and relationship between risk factors and IHD/CeVD. Direct costs to the public health-care system and indirect costs from lost production due to premature mortality, hospitalizations, disability, and absenteeism were considered. Results: We estimated that in 2016, 3.4 million Turkish adults were living with CVD, including 2.5 million affected by IHD, and 0.9 million by CeVD. This prevalence is projected to increase to 5.4 million by 2035. The economic burden of CVD was estimated at US$10.2 billion in 2016, projected to increase twofold to US$19.4 billion by 2035. Conclusion: Our study confirms that the current burden of CVD is significant, and that it is projected to increase at a steep rate over the next two decades. This growing burden of disease will likely create significant pressure on the public health-care system in the form of direct health-care costs, as well as on society in the form of lost productivity. |
| References: | BMJ. 2002 Aug 3;325(7358):275-6. (PMID: 12153929) Clin Neurol Neurosurg. 2011 Feb;113(2):111-4. (PMID: 21036465) Mol Imaging Radionucl Ther. 2011 Dec;20(3):75-93. (PMID: 23487016) BMC Public Health. 2013 Sep 30;13:896. (PMID: 24079269) Anatol J Cardiol. 2015 Apr;15(4):325-33. (PMID: 25413230) Iran J Public Health. 2014 Jun;43(6):736-48. (PMID: 26110144) Turk Kardiyol Dern Ars. 2015 Jun;43(4):402-9. (PMID: 26142798) Int J Cardiol. 1993 Apr;39(1):23-31. (PMID: 8407004) |
| تواريخ الأحداث: | Date Created: 20181010 Date Completed: 20190528 Latest Revision: 20200225 |
| رمز التحديث: | 20221213 |
| مُعرف محوري في PubMed: | PMC6249532 |
| DOI: | 10.14744/AnatolJCardiol.2018.89106 |
| PMID: | 30297582 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2149-2271 |
|---|---|
| DOI: | 10.14744/AnatolJCardiol.2018.89106 |